Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat.
about
Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuseInteractions of Opioids and HIV Infection in the Pathogenesis of Chronic PainInteraction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System DiseaseHIV, opiates, and enteric neuron dysfunctionHIV-1 Tat exacerbates lipopolysaccharide-induced cytokine release via TLR4 signaling in the enteric nervous system.Evidence that opioids may have toll-like receptor 4 and MD-2 effectsPossible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequencesMorphine exacerbates HIV-1 Tat-induced cytokine production in astrocytes through convergent effects on [Ca(2+)](i), NF-kappaB trafficking and transcriptionMorphine induces expression of platelet-derived growth factor in human brain microvascular endothelial cells: implication for vascular permeabilityMorphine enhances HIV-1SF162-mediated neuron death and delays recovery of injured neuritesEvidence for selection at HIV host susceptibility genes in a West Central African human populationHIV-1 Tat-induced changes in synaptically-driven network activity adapt during prolonged exposure.Human immunodeficiency virus type 1 efficiently binds to human fetal astrocytes and induces neuroinflammatory responses independent of infectionN-acetylcysteine prevents HIV gp 120-related damage of human cultured astrocytes: correlation with glutamine synthase dysfunctionBrain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individualsMorphine increases hippocampal viral load and suppresses frontal lobe CCL5 expression in the LP-BM5 AIDS modelHIV-1 alters neural and glial progenitor cell dynamics in the central nervous system: coordinated response to opiates during maturation.STAT3 and its phosphorylation are involved in HIV-1 Tat-induced transactivation of glial fibrillary acidic proteinProgesterone protects normative anxiety-like responding among ovariectomized female mice that conditionally express the HIV-1 regulatory protein, Tat, in the CNS.Regional heterogeneity and diversity in cytokine and chemokine production by astroglia: differential responses to HIV-1 Tat, gp120, and morphine revealed by multiplex analysisInteractive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neuronsRole of CD38, a cyclic ADP-ribosylcyclase, in morphine antinociception and tolerance.Interactive HIV-1 Tat and morphine-induced synaptodendritic injury is triggered through focal disruptions in Na⁺ influx, mitochondrial instability, and Ca²⁺ overload.beta-Chemokine production by neural and glial progenitor cells is enhanced by HIV-1 Tat: effects on microglial migration.Effects of HIV-1 Tat on enteric neuropathogenesis.Towards nanomedicines for neuroAIDS.Activation of Egr-1 expression in astrocytes by HIV-1 Tat: new insights into astrocyte-mediated Tat neurotoxicity.Plasma cytokine concentrations associated with HIV/hepatitis C coinfection are related to attention, executive and psychomotor functioning.HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines.Astrocyte atrophy and immune dysfunction in self-harming macaques.Ibudilast (AV411), and its AV1013 analog, reduce HIV-1 replication and neuronal death induced by HIV-1 and morphineHIV-1 and morphine regulation of autophagy in microglia: limited interactions in the context of HIV-1 infection and opioid abuse.Molecular mechanisms involved in HIV-1 Tat-mediated induction of IL-6 and IL-8 in astrocytes.Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuseGlial-restricted precursors: patterns of expression of opioid receptors and relationship to human immunodeficiency virus-1 Tat and morphine susceptibility in vitro.Gene expression profiles of HIV-1-infected glia and brain: toward better understanding of the role of astrocytes in HIV-1-associated neurocognitive disorders.Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS.Sensitization of enteric neurons to morphine by HIV-1 Tat protein.Morphine stimulates CCL2 production by human neurons
P2860
Q26746336-681B8BDB-6B3A-4849-822B-A1375CF18043Q26768068-69A9020B-6640-4266-AAB6-BA36A1F94D14Q26770397-82C1E454-E4C5-400E-B3F8-E8FF2FBF18ABQ27023420-FD0B953B-80AA-4FE1-8233-610D1856E030Q27318687-8E635D01-3517-46AE-AD4A-5D436043FCA5Q28254885-2CC68F10-0689-47B3-AC54-A64A0E394BD6Q28274052-D2B9D4FB-8205-4EE9-9E12-A2BDB3C42DD0Q28474433-56651735-0C29-4946-A6EB-0805E6B04F4EQ28478866-6B544C3B-1248-42C3-BB4E-F1CFB177DA56Q28539889-7A6A19ED-3CFC-4397-B771-D13D986EDEABQ28710092-A9138A66-0414-4652-8D87-53DA44F44BDCQ30638542-8910EAD8-5022-4379-A4B2-F547B519A09CQ33284463-A11039EB-C71A-4EFD-A050-BA962A53EF95Q33308928-5B183F23-8CEC-4149-A906-9D49E91634B7Q33614467-F825C4D1-54C0-4ADA-B260-BEC30DEDE723Q33632272-C1E55600-D7E3-4D2E-89D9-E79D3CF4F89AQ33647438-446A952E-2CD6-4019-AF66-F6B4964E60E9Q33675464-5A1F7ECC-C168-47F9-9651-1D46C3A1EDFAQ33795961-4E53BBD0-7C50-4C8A-992A-0BBCD0524E9EQ33797852-C0CEBD51-B467-45A9-BA6D-C6D39DDD8CC1Q34086976-F5B6DF33-394B-4D63-94D4-20CF2C9DFA4AQ34128891-8315EC46-2DDC-4D5E-A3C2-F7B1566B96DBQ34197724-C8527F87-E36A-4C1F-9514-E936F518EEEFQ34356438-AAF2616C-6449-4A0A-A25B-4411970750AEQ34383417-80F84A14-1981-472A-BC9C-E04D2174419CQ34495140-25C23EF7-8E4A-4392-842A-306BFD8DE19FQ34666037-95C311C0-A82F-47C9-A286-7EFCCC35DE66Q34778881-E7A6B7AF-1E92-4898-88DB-1DB45F643C49Q34797566-C2A6B8F4-E3F9-4FED-8AC9-C02CD1B6368BQ34905273-AD1F22EB-A8E9-45E5-A0FC-284FA929DA3EQ34988973-B324C6A3-B7A5-4D7A-B61C-9DF1654EB2B7Q34990993-7C2F2739-3B11-442C-A66E-66A800A4E8FAQ34998247-8A796BE7-09C4-4995-979D-DD3F6007AEC2Q35007339-EC985493-82D4-4BCF-A139-CC1A048959C9Q35009465-9BCB2290-C2B0-477E-9669-E5670FA04DA0Q35019404-15A3E4EC-6805-475D-A3BF-D8E58A38C7DAQ35022812-A57442ED-B7F8-44F6-9209-7C12DB45A0B3Q35177355-D7EF15B1-6EF9-4258-87AC-2ED870174992Q35236345-C38E8A34-9F4B-443A-9052-59026431EE4CQ35238188-BB89C8E9-5C50-42AB-906A-2C99F7FCA3B6
P2860
Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Synergistic increases in intra ...... ed with opiates and HIV-1 Tat.
@en
type
label
Synergistic increases in intra ...... ed with opiates and HIV-1 Tat.
@en
prefLabel
Synergistic increases in intra ...... ed with opiates and HIV-1 Tat.
@en
P2093
P2860
P356
P1433
P1476
Synergistic increases in intra ...... ed with opiates and HIV-1 Tat.
@en
P2093
Avindra Nath
Indrapal N Singh
Julie A Gurwell
Kurt F Hauser
Nazira El-Hage
Pamela E Knapp
P2860
P304
P356
10.1002/GLIA.20148
P577
2005-04-01T00:00:00Z